Low Dose Cytosine Arabinoside Regimen for Overt Leukemia, Hypoplastic Leukemia and Myelodysplastic Syndromes : Hypoplastic Leukemia Responds Best.
暂无分享,去创建一个
M. Tomonaga | Y. Yoshida | T. Kohno | I. Jinnai | M. Tagawa | M. Ichimaru | K. Kuriyama | H. Nonaka
[1] K. Foon,et al. Therapy of acute myelogenous leukemia. , 1992, Blood reviews.
[2] G. Fasola,et al. Cell kinetic effect of low dose arabinosyl cytosine , 1987, British journal of haematology.
[3] R. Gale,et al. Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. , 1987, Leukemia.
[4] Gale Rp,et al. Therapy of acute myelogenous leukemia. , 1987, Seminars in hematology.
[5] L. Glasser,et al. Hypoplastic acute leukemia: Review of 70 cases with multivariate regression analysis , 1986, Hematological oncology.
[6] T. Naoe,et al. [Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients]. , 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[7] H. Tilly,et al. Low-dose cytarabine: persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.
[8] F. Naeim,et al. Hypocellular bone marrow with increased blasts , 1986, American journal of hematology.
[9] D. Budman,et al. Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days. , 1985, Cancer research.
[10] J. Griffin,et al. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Tomonaga,et al. Low‐dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8‐trisomy: in vitro and in vivo evidence for normal haematopoietic recovery , 1985, British journal of haematology.
[12] F. Sigaux,et al. Low‐dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients , 1985, Cancer.
[13] D. Hossfeld,et al. Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effect. , 1985, Leukemia research.
[14] E. Orlandi,et al. Low‐dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia , 1985, American journal of hematology.
[15] H. Ishikura,et al. The effect of low dose Ara‐C in acute non‐lymphoblastic leukaemias and atypical leukaemia , 1984, British journal of haematology.
[16] J. Lotem,et al. Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia. , 1984, Leukemia research.
[17] Paton Dm,et al. Therapy of chancroid with trimethoprim-sulfametrole. , 1983 .
[18] G. Mufti,et al. Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia. , 1983, The New England journal of medicine.
[19] J. Griffin,et al. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. , 1983, The New England journal of medicine.
[20] H. Tilly,et al. Does treatment with ARA-C in low dosage cause differentiation of leukemic cells? , 1983, Blood.
[21] A. Manoharan. Low-dose cytarabine therapy in hypoplastic acute leukemia. , 1983, The New England journal of medicine.
[22] R. Fanin,et al. Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia. , 1983, Leukemia research.
[23] A. Hagenbeek,et al. Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: results of a pilot study in four patients. , 1983, Leukemia research.
[24] M. Housset,et al. Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? , 1982, British journal of haematology.
[25] C. Bloomfield,et al. Hypocellular acute leukemia. , 1982, The American journal of medicine.
[26] J. Armitage,et al. Hypoplastic acute leukemia , 1981, Cancer.
[27] K. Foon,et al. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. , 1981, Blood.
[28] L. Sachs,et al. Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cells , 1980, International journal of cancer.
[29] M. Baccarani,et al. DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPY , 1979, British journal of haematology.
[30] C S PETTY,et al. NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY. , 1965, American journal of clinical pathology.